Abstract
The design of effective gene delivery systems for gene transfer in primary human blood cells is important both for fundamental hematopoiesis research and for cancer gene therapy strategies. Here, we evaluated electroporation as a nonviral means for transfection of activated human T lymphocytes and adult bone marrow (BM) CD34+ cells. We describe optimal culture and electroporation parameters for efficient gene delivery in prestimulated T lymphocytes (16.3 ± 1.3%), as well as 2-day cultured adult BM CD34+ cells (29.6 ± 4.6%). PHA-stimulated T cells were most receptive for transfection after 48h of in vitro culture, while T cells stimulated by CD3 cross-linking and interleukin (IL)-2 achieved maximum transfection levels after 72 h of prestimulation. Kinetic analysis of EGFP expression revealed that activated T lymphocytes maintained transgene expression at high levels for a prolonged period. In addition, fresh unstimulated BM CD34+ cells were consistently transfected (5.2 ± 0.4%) with minimal cytotoxicity (<5%), even without preliminary cd34+ cell purification. Both T cells and CD34+ cells retained their phenotype and functional capacity after electroporation. These results demonstrate that electroporation is a suitable nonviral transfection technique that may serve applications in gene therapy protocols using T lymphocytes or CD34+ cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nienhuis AW et al. Gene transfer into hematopoietic cells Stem Cells 1997 15 (Suppl. 1): 123–134
Anderson WF . Human gene therapy Nature 1998 392: 25–30
Moritz T, Williams DA . Gene transfer into the hematopoietic system Curr Opin Hematol 1994 1: 423–428
Wu AG et al. Improvement of gene transduction efficiency in T lymphocytes using retroviral vectors Hum Gene Ther 1999 10: 977–982
Glimm H et al. Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing medium Hum Gene Ther 1998 9: 771–778
Hatzfeld A et al. Increased stable retroviral gene transfer in early hematopoietic progenitors released from quiescence Hum Gene Ther 1996 7: 207–213
Ye ZQ et al. Cytokine transgene expression and promoter usage in primary CD34+ cells using particle-mediated gene delivery Hum Gene Ther 1998 9: 2197–2205
Verma S et al. Gene transfer into human umbilical cord blood-derived CD34+ cells by particle-mediated gene transfer Gene Therapy 1998 5: 692–699
Ledley FD . Nonviral gene therapy: the promise of genes as pharmaceutical products Hum Gene Ther 1995 6: 1129–1144
Harrison GS et al. Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cells Biotechniques 1995 19: 816–823
Floch V et al. Cationic phosphonolipids as non viral vectors for DNA transfection in hematopoietic cell lines and CD34+ cells Blood Cells Mol Dis 1997 23: 69–87
Featherstone C . Electroporation: an effective technique for drug delivery and gene therapy Am Biotechnol Lab 1993 11: 16
Keating A, Toneguzzo F . Gene transfer by electroporation: a model for gene therapy Prog Clin Biol Res 1990 333: 491–498
Matthews KE, Dev SB, Toneguzzo F, Keating A . Electroporation for gene therapy Meth Mol Biol 1995 48: 273–280
Muramatsu T, Nakamura A, Park HM . In vivo electroporation: a powerful and convenient means of nonviral gene transfer to tissues of living animals (review) Int J Mol Med 1998 1: 55–62
Van Tendeloo V et al. Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells Gene Therapy 1998 5: 700–707
Satoh E et al. Successful transfer of ADA gene in vitro into human peripheral blood CD34+ cells by transfecting EBV-based episomal vectors FEBS Lett 1998 441: 39–42
Ebert O et al. Lymphocyte apoptosis: induction by gene transfer techniques Gene Therapy 1997 4: 296–302
Cheng L et al. A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells Gene Therapy 1997 4: 1013–1022
Weaver JC . Electroporation theory. Concepts and mechanisms Meth Mol Biol 1995 55: 3–28
Baum C, Forster P, Hegewisch BS, Harbers K . An optimized electroporation protocol applicable to a wide range of cell lines Biotechniques 1994 17: 1058–1062
Cron RQ, Schubert LA, Lewis DB, Hughes CC . Consistent transient transfection of DNA into non-transformed human and murine T-lymphocytes J Immunol Meth 1997 205: 145–150
Reeves ME et al. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene Cancer Res 1996 56: 5672–5677
Hwu P et al. Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans J Immunol 1993 150: 4104–4115
Gallot G et al. Human HLA-specific T-cell clones with stable expression of a suicide gene: a possible tool to drive and control a graft-versus-host graft-versus-leukemia reaction? Blood 1996 88: 1098–1103
Dorrell C et al. Expansion of human cord blood CD34(+)CD38(−) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function Blood 2000 95: 102–110
Kiem HP et al. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor Blood 1998 92: 1878–1886
Smith C . Retroviral vector-mediated gene transfer into hematopoietic cells: prospects and issues J Hematother 1992 1: 155–166
Yonemura Y, Ku H, Lyman SD, Ogawa M . In vitro expansion of hematopoietic progenitors and maintenance of stem cells: comparison between FLT3/FLK-2 ligand and KIT ligand Blood 1997 89: 1915–1921
Cooper MJ . Noninfectious gene transfer and expression systems for cancer gene therapy Semin Oncol 1996 23: 172–187
Gomez NJ, Curiel DT, Douglas JT . Gene therapy for cancer Eur J Cancer 1999 35: 867–885
Bergan R et al. Electroporation of synthetic oligodeoxynucleotides: a novel technique for ex vivo bone marrow purging Blood 1996 88: 731–741
Buhring HJ et al. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells Leukemia 1991 5: 854–860
Lardon F et al. Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1 Immunology 1997 91: 553–559
Acknowledgements
This work was supported by grant No. 3.0109.96 and No. G.0157.99 of the Fund for Scientific Research, Flanders, Belgium (FWO), by a grant of the Scientific Committee of the ASLK-financed Cancer Research and by gifts of Mrs Ellie Van Belleghem to the HEBA Foundation (Foundation for Hematology, Bone Marrow Transplantation and Blood Transfusion, Antwerp) in memory of her late mother Louisa De Saedeleer. We would like to thank Dr SC Lyman and Dr EK Thomas (Immunex Corporation, Seattle, WA, USA) for providing us with Flt-3 ligand, Dr John Wunderlich (NIH, Bethesda, USA) for the 1235 Melan-A-specific TIL clone. VVT is a research assistant of the FWO. RW is a holder of a research grant of the Vlaamse Kankerliga. PP is holder of a research grant of the Institute for Science and Technology (IWT).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Tendeloo, V., Willems, R., Ponsaerts, P. et al. High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery. Gene Ther 7, 1431–1437 (2000). https://doi.org/10.1038/sj.gt.3301252
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301252
Keywords
This article is cited by
-
Steroid receptor coactivator 3 (SRC-3/AIB1) is enriched and functional in mouse and human Tregs
Scientific Reports (2021)
-
Optimized DNA electroporation for primary human T cell engineering
BMC Biotechnology (2018)
-
T-cell receptor transfer into human T cells with ecotropic retroviral vectors
Gene Therapy (2014)
-
In vivo imaging of T cells loaded with gold nanoparticles: a pilot study
La radiologia medica (2014)
-
Targeted gene knockout by direct delivery of zinc-finger nuclease proteins
Nature Methods (2012)